Copyright
©The Author(s) 2019.
World J Gastroenterol. Feb 28, 2019; 25(8): 955-966
Published online Feb 28, 2019. doi: 10.3748/wjg.v25.i8.955
Published online Feb 28, 2019. doi: 10.3748/wjg.v25.i8.955
Figure 2 Effects of procyanidin B2 on serum lipid profile, insulin resistance, and endotoxemia.
Serum triglycerides (A), total cholesterol (B), low-density lipoprotein cholesterol (C), high-density lipoprotein cholesterol (D) and fasting glucose (E), fasting insulin (F) and the intravenous glucose tolerance test (G), units of area under the curve (H) and lipopolysaccharides (I). The data are expressed as means ± SD. aP < 0.05 vs CHOW group; bP < 0.05 vs high-fat-cholesterol diet group. HCD: High-fat-cholesterol diet; PB2: Procyanidin B2; LDL-C: Low-density lipoprotein cholesterol; HDL-C: High-density lipoprotein cholesterol; IVGTT: Intravenous glucose tolerance test; AUC: Area under the curve; LPS: Lipopolysaccharides; SD: Standard deviation.
- Citation: Xing YW, Lei GT, Wu QH, Jiang Y, Huang MX. Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease via the modulation of the gut microbiota in rabbits. World J Gastroenterol 2019; 25(8): 955-966
- URL: https://www.wjgnet.com/1007-9327/full/v25/i8/955.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i8.955